Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Voglibose Tablets bulk supplier for pharma manufacturers

Voglibose Tablets 0.2 mg, 0.3 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.2 mg, 0.3 mg

Reference Brands: Volix®, Vocarb®, Voglimet®, Basen®(EU/Asia)

Category: Diabetes

Voglibose works by inhibiting intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and glucose absorption. This helps control post-meal blood sugar spikes. It is particularly beneficial for managing postprandial hyperglycemia in type 2 diabetes, improving glycemic control without causing significant hypoglycemia when used as monotherapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Voglibose is an oral alpha-glucosidase inhibitor used primarily for the management of postprandial blood glucose levels in type 2 diabetes mellitus. It is not FDA-approved in the United States and thus not commercially available there. In the European Union, Voglibose is not broadly authorized but may be marketed in specific regions under national licenses. The drug is extensively approved and utilized in countries like India and Japan, where it is sold under various brand names. It is often used alone or in combination with other antidiabetic agents. Regulatory approvals focus on its efficacy in delaying glucose absorption.

Voglibose Tablets — third party manufacturing & bulk supply

Voglibose Tablets 0.2 mg, 0.3 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Voglibose Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Voglibose Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Voglibose Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Voglibose Tablets is listed as Tablets in 0.2 mg, 0.3 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Voglibose Tablets is referenced against Volix®, Vocarb®, Voglimet®, Basen®(EU/Asia). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Voglibose Tablets is catalogued under Diabetes on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Repaglinide

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Prandin (USA)

View Details
Pioglitazone Hydrochloride 150Mg Tablet

Strength:
15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Actos (USA)

View Details
Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View Details
Miglitol

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Glyset (USA), Diastabol (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.